A few misconceptions tend to follow discussions of Mexican pharmaceutical industry. One is assuming there’s nothing to verify: in reality, COFEPRIS, Mexico’s health regulator, oversees registration, manufacturing standards, and pharmacy licensing nationwide. Another common assumption gets the details backwards on cost or convenience, when in fact both brand-name and generic products must clear COFEPRIS registration before they can legally be sold. A third misunderstanding overlooks a practical detail that matters more than people expect: the market includes domestic Mexican manufacturers alongside Mexican subsidiaries of multinational drug companies. Clearing up these points ahead of time makes for a much more informed approach to Mexican pharmaceutical industry.